Views of Practitioners and Researchers on the Use of Virtual Reality in Treatments for Substance Use Disorders.
avatars
cognitive behavioral therapy
coping
craving
mental health
substance abuse
therapists
virtual reality exposure therapy
Journal
Frontiers in psychology
ISSN: 1664-1078
Titre abrégé: Front Psychol
Pays: Switzerland
ID NLM: 101550902
Informations de publication
Date de publication:
2021
2021
Historique:
received:
15
09
2020
accepted:
27
04
2021
entrez:
7
6
2021
pubmed:
8
6
2021
medline:
8
6
2021
Statut:
epublish
Résumé
Virtual Reality Therapy (VRT) has been shown to be effective in treating anxiety disorders and phobias, but has not yet been widely tested for Substance Use Disorders (SUDs) and it is not known whether health care practitioners working with SUDs would use VRT if it were available. We report the results of an interview study exploring practitioners' and researchers' views on the utility of VRT for SUD treatment. Practitioners and researchers with at least two years' experience delivering or researching and designing SUD treatments were recruited (
Identifiants
pubmed: 34093303
doi: 10.3389/fpsyg.2021.606761
pmc: PMC8175665
doi:
Types de publication
Journal Article
Langues
eng
Pagination
606761Informations de copyright
Copyright © 2021 Skeva, Gregg, Jay and Pettifer.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Front Neurosci. 2020 Jan 10;13:1409
pubmed: 31998066
Clin Psychol Rev. 2017 Nov;57:195-207
pubmed: 28781153
J Subst Abuse Treat. 2019 Jan;96:26-32
pubmed: 30466545
Fam Med Community Health. 2019 Mar 8;7(2):e000057
pubmed: 32148704
Front Hum Neurosci. 2014 Oct 17;8:844
pubmed: 25368571
Addict Behav. 2018 Jun;81:1-11
pubmed: 29421343
J Subst Abuse Treat. 2019 Apr;99:104-116
pubmed: 30797382
Addiction. 2021 Mar;116(3):658-667
pubmed: 32511812
J Psychosoc Nurs Ment Health Serv. 2019 Jun 1;57(6):15-19
pubmed: 31162622
Clin Psychol (New York). 2020 Sep;27(3):
pubmed: 33223628
Front Hum Neurosci. 2020 Mar 31;14:124
pubmed: 32296322
Front Psychol. 2020 Jun 05;11:1242
pubmed: 32581979
J Affect Disord. 2019 Oct 1;257:698-709
pubmed: 31382122
Curr Addict Rep. 2020 Sep;7(3):291-300
pubmed: 33738178
J Clin Med. 2018 Mar 04;7(3):
pubmed: 29510528
Epilepsy Behav. 2013 Aug;28(2):227-31
pubmed: 23773979
Psychol Med. 2018 Feb;48(3):362-391
pubmed: 28735593
Neurotherapeutics. 2017 Jul;14(3):554-563
pubmed: 28512692
Sci Rep. 2018 Jul 9;8(1):10323
pubmed: 29985400
J Psychiatr Res. 2019 Sep;116:88-94
pubmed: 31226580
Am Psychol. 1992 Sep;47(9):1102-14
pubmed: 1329589
Body Image. 2020 Jun;33:232-243
pubmed: 32408166
Eur Addict Res. 2017;23(4):177-181
pubmed: 28803249
Epilepsy Behav. 2014 Feb;31:57-66
pubmed: 24361763
Behav Sci (Basel). 2017 Jul 09;7(3):
pubmed: 28698483
Front Psychol. 2019 Feb 08;10:176
pubmed: 30800086
Soa Chongsonyon Chongsin Uihak. 2020 Jan 1;31(1):26-32
pubmed: 32612410
Soc Psychiatry Psychiatr Epidemiol. 2007 May;42(5):343-54
pubmed: 17431528
Psychol Serv. 2012 Aug;9(3):310-5
pubmed: 22867123
Glob Qual Nurs Res. 2015 Aug 14;2:2333393615597674
pubmed: 28462313
Epilepsy Behav. 2011 Oct;22(2):364-9
pubmed: 21873120
Cyberpsychol Behav Soc Netw. 2011 Jan-Feb;14(1-2):29-34
pubmed: 21329440
Sci Rep. 2019 Mar 14;9(1):4519
pubmed: 30872760